Comparing drug combinations for graft-versus-host disease prophylaxis using the U.S. Food and Drug Administration Adverse Event Reporting System

Background : Graft-versus-host disease (GVHD) is a severe complication for transplant patients, particularly those undergoing allogeneic hematopoietic stem cell transplantation. Although various GVHD prophylaxis drug combinations are administered in clinical settings, previous studies have primarily...

Full description

Saved in:
Bibliographic Details
Main Authors: Toru Ogura, Chihiro Shiraishi, Aiko Urawa
Format: Article
Language:English
Published: The Korean Society for Transplantation 2025-06-01
Series:Clinical Transplantation and Research
Subjects:
Online Access:https://www.ctrjournal.org/journal/view.html?doi=10.4285/ctr.24.0049
Tags: Add Tag
No Tags, Be the first to tag this record!